Also, other experiences have revealed that blocking the secretion or activity of soluble S100A8/A9 sophisticated may be a promising therapeutic tactic in surviving people, who had lower levels of S100A8/A9, compared to non-survivors. The blocking has the possible to avoid liver damage and bacterial dissemination from the early levels of sepsis and